Published By
Created On
30 Mar 2023 02:26:19 UTC
Transaction ID
Cost
Safe for Work
Free
Yes
Dr. John Campbell - London research
29 Mar 2023
"British experiments
https://www.telegraph.co.uk/news/2023/03/18/how-british-experiments-risked-making-covid-pandemic-lethal/
Risked making the Covid pandemic ‘more lethal’
In testing, Imperial College London
Experiments took place in London
Supported by the UK Health Security Agency (UKHSA)
Cells were infected with delta and omicron,
at the same time,
to see which had a competitive advantage.
Professor Anton van der Merwe, molecular immunology, University of Oxford
Risked combining the two variants,
to produce something “more lethal”
Infected scientists, could walk out of the lab.
“Coronaviruses like Sars-CoV-2 are well known to ‘evolve’ by exchanging genetic material,
when two distinct viruses infect the same cell,”
This makes it much more likely that these two strains will recombine,
and create a more dangerous variant,
which could infect those doing the experiments,
who could then spread it into the community.”
Using delta and omicron, particularly risky,
from different lineages, with significant differences
Professor Anton van der Merwe,
There is more opportunity for recombination in animal experiments and selection for more dangerous variants because they involve more cells infected for longer periods,
Handling animals is also riskier in terms of transmission to the experimenter than handling cells.
Neither of these experiments are of any help in protecting us from Sars-CoV-2.
Dr Filippa Lentzos, Centre for Science and Security Studies King’s College London
“There has been a global boom in construction of labs handling dangerous pathogens, but this has not been accompanied by sufficient biosafety and biosecurity oversight.”
Imperial College London
“This government-backed research used viruses no more pathogenic than those already circulating within the population and will provide crucial insights that support government decision-making on how to manage the pandemic.
“It was conducted in a biosafety level three laboratory in line with strict government regulations, and received ongoing approval from the Health and Safety Executive.”
https://consteril.com/biosafety-levels-difference/
Wuhan IV, biosafety level 4 (BSL4)
One of 59 around the world
Three quarters in urban settings (like London)
Past lab leaks
Smallpox, swine flu, SARS, anthrax, foot and mouth disease
Report by King’s College London
https://www.kcl.ac.uk/fifty-nine-labs-around-world-handle-the-deadliest-pathogens-only-a-quarter-score-high-on-safety
Did the coronavirus SARS-CoV-2 result from high-risk research gone wrong?
The risk of future pandemics originating from research with dangerous pathogens is real.
BSL4 labs
Europe, 25 labs
North America, 14 and
Asia, 13
Australia, 4
Africa,3
With 3,000m² of lab space, the Wuhan Institute of Virology is the largest BSL4 lab in the world"
Original: https://www.youtube.com/watch?v=hqs3E9wsbwA
"British experiments
https://www.telegraph.co.uk/news/2023/03/18/how-british-experiments-risked-making-covid-pandemic-lethal/
Risked making the Covid pandemic ‘more lethal’
In testing, Imperial College London
Experiments took place in London
Supported by the UK Health Security Agency (UKHSA)
Cells were infected with delta and omicron,
at the same time,
to see which had a competitive advantage.
Professor Anton van der Merwe, molecular immunology, University of Oxford
Risked combining the two variants,
to produce something “more lethal”
Infected scientists, could walk out of the lab.
“Coronaviruses like Sars-CoV-2 are well known to ‘evolve’ by exchanging genetic material,
when two distinct viruses infect the same cell,”
This makes it much more likely that these two strains will recombine,
and create a more dangerous variant,
which could infect those doing the experiments,
who could then spread it into the community.”
Using delta and omicron, particularly risky,
from different lineages, with significant differences
Professor Anton van der Merwe,
There is more opportunity for recombination in animal experiments and selection for more dangerous variants because they involve more cells infected for longer periods,
Handling animals is also riskier in terms of transmission to the experimenter than handling cells.
Neither of these experiments are of any help in protecting us from Sars-CoV-2.
Dr Filippa Lentzos, Centre for Science and Security Studies King’s College London
“There has been a global boom in construction of labs handling dangerous pathogens, but this has not been accompanied by sufficient biosafety and biosecurity oversight.”
Imperial College London
“This government-backed research used viruses no more pathogenic than those already circulating within the population and will provide crucial insights that support government decision-making on how to manage the pandemic.
“It was conducted in a biosafety level three laboratory in line with strict government regulations, and received ongoing approval from the Health and Safety Executive.”
https://consteril.com/biosafety-levels-difference/
Wuhan IV, biosafety level 4 (BSL4)
One of 59 around the world
Three quarters in urban settings (like London)
Past lab leaks
Smallpox, swine flu, SARS, anthrax, foot and mouth disease
Report by King’s College London
https://www.kcl.ac.uk/fifty-nine-labs-around-world-handle-the-deadliest-pathogens-only-a-quarter-score-high-on-safety
Did the coronavirus SARS-CoV-2 result from high-risk research gone wrong?
The risk of future pandemics originating from research with dangerous pathogens is real.
BSL4 labs
Europe, 25 labs
North America, 14 and
Asia, 13
Australia, 4
Africa,3
With 3,000m² of lab space, the Wuhan Institute of Virology is the largest BSL4 lab in the world"
Original: https://www.youtube.com/watch?v=hqs3E9wsbwA
Author
Content Type
Unspecified
video/mp4
Language
English
More from the publisher
Controlling
VIDEO
DAY O
DOTR07
3 May 2022
"Powered by Restream https://restre.am/yt
https://streamerlinks.com/Nathan_Smith"
Original: https://www.youtube.com/watch?v=FVyvEJbl5CE
Transaction
Created
4 weeks ago
Content Type
Language
video/mp4
English
VIDEO
TDOTR
pvt001
No description available
Transaction
Created
4 weeks ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DAY O
DOTR08
14 Jun 2022
"Powered by Restream https://restre.am/yt
https://streamerlinks.com/Nathan_Smith"
Original: https://www.youtube.com/watch?v=8xTAuKwK0LI
Transaction
Created
4 weeks ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DR. J
drjohncampbell60
24 Dec 2022
"Sun Yang, Chinese Center for Disease Control and Prevention
https://www.msn.com/en-us/news/world/china-estimates-250-million-people-caught-covid-19-since-end-of-zero-covid-policy-report/ar-AA15D8xp
https://www.msn.com/en-gb/news/world/china-s-covid-surge-sees-37-million-new-cases-in-single-day-as-hospitals-struggle/ar-AA15BPtg
Closed-door meeting
Infections, Tuesday, 37 million
205 million so far (18% of the population)
Beijing, Shanghai, Sichuan, 50% infected so far
Thursday, cases, + 4,000
Saturday, cases + 4,103
Deaths, + 8
(no attempt to collate cases)
Institute for Health Metrics and Evaluation (IHME)
(University of Washington, Seattle)
https://covid19.healthdata.org/china?view=cumulative-deaths&tab=trend
Deaths by April 1st = 293,127
Population 1,412,600,000
Infection fatality rate = 0.000207
From China
Lots of people have colds
Chengdu
Monday the 5th of December 2022, local government loosened all covid restrictions
By the 12th, almost everyone I know has covid
Severe stigma associated with the virus
About 80% have symptoms
20% asymptomatic
Symptoms
Headache (with brain fog)
Lack of energy/fatigue
Muscle pain
Body pains
(Seem universal)
Also
Dry throat
Slight cough
Runny nose (usually light)
Nausea
Insomnia
Diarrhea
Increased appetite in some
Very little testing going on
Few government testing centres
Many determined to know, long queues
People still think the virus is very dangerous
Getting negative results (despite being symptomatic)
Avoid panic
Avoid shutdowns
Promote natural immunity
Moderna Chief Executive Stephane Bancel
https://www.cnbc.com/2022/06/22/moderna-to-build-new-vaccine-facility-in-britain.html
That capacity that we’re building in the UK, that they are committed to buying the product for the next ten years
NOTES TO EDITORS:
the details of the strategic partnership between the government and Moderna are commercially sensitive
UK, Prime Minister, Moderna (2020)
https://www.theguardian.com/politics/2020/nov/17/rishi-sunak-refuses-to-say-if-he-will-profit-from-moderna-covid-vaccine
Mr. Sunak refused to disclose whether he will profit from a surge in the share price of Moderna
Theleme has a $500m investment in US-based Moderna
Mr. Sunak was a founding partner of Theleme Partners
and one of the executives managing its US office.
He left the firm in 2013
Theleme is registered in the Cayman Islands
(which does not make company records public)
Moderna goes global
https://globalnews.ca/news/9258211/groundbreaking-moderna-mrna-vaccine-factory-montreal/
Canada
New factory in Montreal area, Laval, Que
Mr. Trudeau took part in a groundbreaking ceremony
Completed in 2024 or 2025
mRNA vaccines, 100 million doses per year
Covid, influenza, respiratory syncytial virus
Innovation Minister François-Philippe Champagne
Canada committed to purchase a certain number of vaccines
Part of a seven-year agreement
200+ workforce
No to leave out Australia
https://www.monash.edu/news/articles/moderna-to-build-manufacturing-facility-at-monash
Monash Technology Precinct, Victoria
COVID-19, influenza and respiratory syncytial virus (RSV)
100 million doses per year
mRNA vaccines
Monash Vice-Chancellor, Professor Margaret Gardner
bring together all of the elements of an mRNA innovation ecosystem
that will deliver long-term health and economic benefits for the community"
Original: https://www.youtube.com/watch?v=AH3AFYVn3T8
Transaction
Created
4 weeks ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
PETER
PB_PHI106_WR_02
"In this first video for PHIL 106: World Religions at Southwestern College, we begin exploring the meaning of religion, and the idea of God (or gods)."
Transaction
Created
4 weeks ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DR. J
drjohncampbell117
30 Mar 2023
"Covid symptom data mild, excess deaths high
https://health-study.joinzoe.com
Sore throat 59%
Runny nose 54%
Blocked nose 52%
Headache 51%
Sneezing 50%
Cough, no phlegm 49%
Cough with Phlegm 41%
Hoarse voice 36%
Muscle aches pains 27%
Fatigue 20%
Altered smell 20%
Dizzy light headed 19%
Swollen neck glands 17%
Sore eyes 16%
Loss of smell 16%
Chest pain tightness 14%
Short of breaths 13%
Earache 13%
Shivers or chills 13%
Fever 11%
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsregisteredweeklyinenglandandwalesprovisional/weekending17march2023
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/latest
England
Estimated number of people testing positive for COVID-19
1,493,200
Equating to 2.66% of the population,
or around 1 in 40 people.
Week ending 17 March 2023 (Week 11)
12,133 deaths registered in England and Wales
559 deaths mentioned novel coronavirus (COVID-19),
accounting for 4.6% of all deaths.
Of the 559 deaths involving COVID-19
67.3% (376 deaths) had this recorded as the underlying cause of death
The number of deaths was above the five-year average
In private homes 23.2% above, (674 excess deaths)
In hospitals 4.6% above,
(232 excess deaths)
In care homes 4.7% above,
(112 excess deaths)
In other settings 6.9% above, (55 excess deaths)
Number of deaths registered in the UK in the week ending 17 March 2023
13,683, (9.3% above the five-year average)
Thats 1,169 more deaths than the five-year average
Excess deaths
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/monthlymortalityanalysisenglandandwales/december2022#excess-mortality-in-england-and-wales
The difference between the observed deaths within a period compared with the five-year average (2016 to 2019, and 2021)
Probably multifactorial
Excess deaths have occurred around the world
Let’s look for a common (or group of) underlying cause that would explain the tragedy.
It may transpire there is a common factor (s)"
Original: https://www.youtube.com/watch?v=pzhI0FobVtQ
Transaction
Created
4 weeks ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DRBEE
drbeen04
Persistent MRI Findings in Children After Pfizer Vaccine Myopericarditis. Seattle Children's Hospital
In this study, the researchers followed up on children that had myocarditis from the second dose of the Pfizer-BioNTech vaccine. Most of the abnormalities had resolved except that the abnormal strain persisted for the majority of the patients.
If you like this content and want more, I am doing a special lifetime membership offer. Click here:
https://www.drbeen.com/yt-special/
Want to support this work?:
https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true
PayPal: https://www.paypal.com/paypalme/mobeensyed?locale.x=en_US
We will go live on this channel today:
YouTube: https://www.youtube.com/channel/UCKt2yqtcxJtqjJujr93yX4A
#drbeen #koolbeens #COVID
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute the provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health-related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Monday, Mar. 28 2022
Persistent Cardiac MRI Findings in a Cohort of Adolescents with post COVID-19 mRNA vaccine myopericarditis - The Journal of Pediatrics
https://www.jpeds.com/article/S0022-3476(22)00282-7/fulltext#relatedArticles
Towards standardized postprocessing of global longitudinal strain by feature tracking – OptiStrain CMR-FT study | BMC Cardiovascular Disorders | Full Text
https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-019-1255-4#:~:text=Left%20ventricular%20global%20longitudinal%20strain,among%20the%20users%20and%20vendors
GLOBAL LONGITUDINAL STRAIN AND GLOBAL CIRCUMFERENTIAL STRAIN IN RELATION TO LATE GADOLINIUM ENHANCEMENT IN CMR | Journal of the American College of Cardiology
https://www.jacc.org/doi/10.1016/S0735-1097%2821%2902754-6
Strain imaging using cardiac magnetic resonance - PMC
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487809/
Assessment of global longitudinal strain using standardized myocardial deformation imaging: a modality independent software approach | Semantic Scholar
https://www.semanticscholar.org/paper/Assessment-of-global-longitudinal-strain-using-a-Riffel-Keller/3c27b2ef65442245e8eb6a0a9efc3ef308c972f9
Global longitudinal strain is a more reproducible measure of left ventricular function than ejection fraction regardless of echocardiographic training | Cardiovascular Ultrasound | Full Text
https://cardiovascularultrasound.biomedcentral.com/articles/10.1186/s12947-019-0168-9#:~:text=%2C%20Grenne%2C%20B.-,Global%20longitudinal%20strain%20is%20a%20more%20reproducible%20measure%20of%20left,fraction%20regardless%20of%20echocardiographic%20training
Global Longitudinal Strain for LV Function - American College of Cardiology
https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2018/08/10/11/01/assessment-of-left-ventricular-global-longitudinal-strain
Late gadolinium enhancement | Radiology Reference Article | Radiopaedia.org
https://radiopaedia.org/articles/late-gadolinium-enhancement-2?lang=us#:~:text=Late%20gadolinium%20enhancement%20is%20a%20result%20of%20regional%20differences%20in,and%20can%20be%20related%20to
Transaction
Created
4 weeks ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DR. J
New-WHO-treaty,-Ester-McVey-MP--v2j26lg-
2 May 2023
Original: https://rumble.com/v2lnm3g-new-who-treaty-ester-mcvey-mp.html
Transaction
Created
4 weeks ago
Content Type
Language
video/mp4
English
Controlling
VIDEO
DR. J
drjohncampbell83
27 Jan 2023
"Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adult
https://pubmed.ncbi.nlm.nih.gov/36055877/
Free full text available
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428332/
3.4. Harm-benefit considerations
In the Moderna trial,
the excess risk of serious AESIs was 15.1 per 10,000 participant
One in 662
(over placebo baselines)
In the Pfizer trial,
the excess risk of serious AESIs 10.1 per 10,000
One in 990
(over placebo baselines)
Combined, mRNA vaccines,
risk of serious adverse events of special interest
12.5 per 10,000 vaccinated
One in 800
(over placebo baselines)
1,250 serious events for each million vaccine recipients
Appendix 1: estimation of number needed to vaccinate to prevent a COVID-19 hospitalisation,
for primary vaccination,
booster vaccination (3rd dose),
autumn 2022 booster and,
spring 2023 booster (for those newly in a risk group)
(Published 25 January 2023)
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1131409/appendix-1-of-jcvi-statement-on-2023-covid-19-vaccination-programme-8-november-2022.pdf
Calculation of numbers needed to vaccinate (NNV)
Table 3: NNV for prevention of hospitalisation for different programmes
20 – 29 Years, Autumn booster
No risk group, 169,200 (706,500)
In a risk group, 7,500 (59,500)
50 – 59 Years, Autumn booster
No risk group, 43,600 (256,400)
In a risk group, 3,100 (18,600)
60 – 69 years, Autumn booster
3,600 (27,300)
70 + Autumn booster
800 (7,500)
Table 1: rates per million of COVID-19 hospitalisation (rates are for July 2022)
1,250 serious events for each million vaccine recipients
Table 1: rates per million of COVID-19 severe hospitalisation (rates are for July 2022)
1,250 serious events for each million vaccine recipients
Based on a UK Health Security Agency (UKHSA) presentation to the Joint Committee on Vaccination and Immunisation (JCVI) on 25 October 2022."
Original: https://www.youtube.com/watch?v=fbFayD_S_54
Transaction
Created
4 weeks ago
Content Type
Language
video/mp4
English